Hu rau:Errol Zhou (Mr.)
Tel: ntxiv 86-551-65523315
Mobile/WhatsApp: ntxiv 86 17705606359
QQ:196299583
Skype:lucytoday@hotmail.com
Email:sales@homesunshinepharma.com
Ntxiv:1002, Huanmao Tsev, No.105, Mengcheng Txoj kev, Hefei Lub zos, 230061 Tuam Tshoj

CAS TSIS TAU: 177036-94-1
Cov mis mos molecular: C22H22N2O4
Molecular phaus: 378.42100
EINECS TSIS MUAJ: 658-059-9
MDL TSIS MUAJ: MFCD09842330
Khoom Piav Qhia:
Khoom Lub Npe: Ambrisentan CAS TSIS TAU: 177036-94-1
Lub ntsiab lus:
Letairis;
(S) -2- (4,6-Dimethylpyrimidin-2-yloxy) -3-methoxy-3,3-diphenylpropanoic acid;
Ambrisentan;
Tshuaj& Lub Cev Muaj Zog:
Tsos: Dawb rau dawb-dawb khoom
Kev Ntsuas: ≥99.00%
Ceev: 1.228g/cm3
Kub Point: 551.1 ℃ ntawm 760mmHg
Flash Point: 287.1 ℃
Refractive Index: 1.593
Vapor Siab: 5.56E-13mmHg ntawm 25 ℃
Cov Ntaub Ntawv Kev Nyab Xeeb:
HS Code: 2933599090
Cov Ntsiab Lus Risk: R62/63
Cov Lus Hais Txog Kev Nyab Xeeb: S53-36/37/39-45
RTECS: UA 2459660
Endothelin -1 (ET -1) yog qhov ua tau zoo autocrine thiab paracrine peptide. Ob lub receptor subtypes (ETA thiab ETB) koom ua lub luag haujlwm ntawm ET-1 hauv cov leeg leeg leeg thiab cov leeg endothelial. Lub luag haujlwm tseem ceeb ntawm ETA yog vasoconstriction thiab kev nthuav dav ntawm tes, thaum lub luag haujlwm tseem ceeb ntawm ETB yog vasodilation, inhibition ntawm kev loj hlob, thiab tshem tawm ET-1.
Yog tias koj txaus siab rau peb cov khoom lossis muaj lus nug, thov koj xav tiv tauj peb!
Cov khoom lag luam nyob rau hauv patent tau muab rau R& D lub hom phiaj nkaus xwb. Txawm li cas los xij, lub luag haujlwm zaum kawg tshwj xeeb tshaj yog nrog tus neeg yuav khoom.
Cim npe nrov: ambrisentan cas 177036-94-1, tuam ntxhab, cov chaw muag khoom, lub Hoobkas, yuav, hauv Tshuag